MCT’s collaboration with Onxeo on HCC Phase III study in Middle East

26 Mar 2015
In: News

Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon, Egypt and Saudi Arabia). More information in Onxeo press release: 150326EN_Livatag

Related Posts